David Edward Johnson

David Edward Johnson has an estimated net worth of $1.55 Billion. This is based on reported shares across multiple companies, which include STANDARD BIOTOOLS INC., Liquidia Corp, EXELIXIS, INC., AMAG PHARMACEUTICALS, INC., ALIMERA SCIENCES INC, and Verrica Pharmaceuticals Inc..

2022 was David Edward Johnson's most active year for acquiring shares with 25 total transactions. David Edward Johnson's most active month to acquire stocks was the month of April. 2023 was David Edward Johnson's most active year for disposing of shares, totalling 6 transactions. David Edward Johnson's most active month to dispose stocks was the month of October. 2023 saw David Edward Johnson paying a total of $41,540,590.67 for 18,247,634 shares, this is the most they've acquired in one year. In 2023 David Edward Johnson cashed out on 17,835,131 shares for a total of $4,564,848.49, their largest year based on trade value.